Abstracts tagged "tobacco use"

Abstract Number: 822 • 2019 ACR/ARP Annual Meeting
Cigarette Smoking Is a Risk Factor for ANCA-Associated Vasculitis
Greg McDermott¹, Xiaoqing Fu ¹, John Stone ², Yuqing Zhang ³, Hyon K. Choi ³ and Zachary Wallace ¹, ¹Massachusetts General Hospital, Boston, ²Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, ³Massachusetts General Hospital, Boston, MA
Background/Purpose: ANCA-associated vasculitis (AAV) is a systemic small vessel vasculitis of unclear etiology associated with excess morbidity and mortality compared to the general population. Environmental…
Abstract Number: 1123 • 2019 ACR/ARP Annual Meeting
Healthcare Factors More Predictive of Smoking Cessation in Patients with Rheumatoid Arthritis Than Patient Characteristics
Maria Schletzbaum¹, Xing Wang ¹, Robert Greenlee ² and Christie Bartels ¹, ¹University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Marshfield Clinic Research Institute, Marshfield, WI
Background/Purpose: Smoking doubles the risk of developing RA, and continuing to smoke after RA diagnosis is associated with worse disease control, treatment failure, and premature…
Abstract Number: 1554 • 2018 ACR/ARHP Annual Meeting
Cigarette Smoking Does Not Affect Treatment Response to Tofacitinib in Rheumatoid Arthritis
Ahmet Karatas¹, Burak Oz², Ediz Dalkiliç³, Gerçek Can⁴, Yavuz Pehlivan⁵, Soner Senel⁶, Ayten Yazici⁷, Nevsun Inanc⁸, Zeynep Erturk⁹, Ayse Cefle⁷, Servet Akar¹⁰, Suleyman Serdar Koca¹¹, Merih Birlik⁴ and Fatos Onen⁴, ¹Department of Rheumatology, Firat University, School of Medicine, Rheumatology, Elazig, Turkey, ²Rheumatology, Firat University, School of Medicine, Rheumatology, Elazig, Turkey, ³Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey, ⁴Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, ⁵Rheumatology, Uludag University, Faculty of Medicine, Bursa, Turkey, ⁶Rheumatology, Kayseri Erciyes University, Faculty of Medicine, Kayseri, Turkey, ⁷Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey, ⁸Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ⁹Department of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey, ¹⁰Department of Internal Medicine, Division of Rheumatology,, Izmir Katip Çelebi University Faculty of Medicine, Izmir, Turkey, ¹¹Rheumatology, Firat University Faculty of Medicine, Elazığ, Turkey
Background/Purpose: Smoking is one of the described risk factors for rheumatoid arthritis (RA) since smoking may induce citrullination of peptide antigens and thus the trigger…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].